DongKoo Bio & Pharma Overview

  • Founded
  • 1970

  • Status
  • Public

  • Employees
  • 370

  • Stock Symbol
  • 006620

Stock Symbol
  • Share Price
  • $4.45

  • (As of Friday Closing)

DongKoo Bio & Pharma General Information


Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.

Contact Information

Formerly Known As
DongKoo Pharm
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • 14F, Building B
  • 114 Beobwon-ro, Songpa-g
  • Seoul, Guro-gu
  • South Korea
+82 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DongKoo Bio & Pharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.45 $4.53 $3.62 - $6.68 $123M 27.6M 103K $0.18

DongKoo Bio & Pharma Financials Summary

In Thousands,
TTM 31-Dec-2022 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 138,304 138,304 187,125 211,191
Revenue 150,906 150,906 135,452 117,910
EBITDA 11,151 11,151 14,625 12,839
Net Income 5,119 5,119 8,143 7,742
Total Assets 136,240 136,240 130,070 132,323
Total Debt 27,177 27,177 20,415 21,764
Public Fundamental Data provided by Morningstar, Inc. disclaimer

DongKoo Bio & Pharma Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DongKoo Bio & Pharma‘s full profile, request access.

Request a free trial

DongKoo Bio & Pharma Patents

DongKoo Bio & Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3466462-A1 Medical injection device Active 25-May-2016 000000000
ES-2848728-T3 Injection medical device Active 25-May-2016 00000000
JP-6529104-B1 Medical infusion system Active 25-May-2016 000000000
JP-2019517897-A Medical infusion system Active 25-May-2016 000000000
US-20190365988-A1 Medical injection device Active 25-May-2016 A61M5/168 0
To view DongKoo Bio & Pharma’s complete patent history, request access »

DongKoo Bio & Pharma Executive Team (2)

Name Title Board Seat Contact Info
Yong-Joon Cho Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

DongKoo Bio & Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial